Removal of BNP and inflammatory cytokines by haemodiafiltration in refractory heart failure [3]

Nephrology Dialysis Transplantation

Volumn 22, Issue 7, 2007, Pages 2093-2094

  Kazory, Amir ^a   Ejaz, A Ahsan ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYTOKINE; DIURETIC AGENT; MEMBRANE METALLOENDOPEPTIDASE;

CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DIURETIC THERAPY; DRUG RESPONSE; EXTRACELLULAR SPACE; FILTRATION; HEART FUNCTION; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HUMAN; HYDRATION; LETTER; PATHOPHYSIOLOGY; PLASMA CLEARANCE; PLASMA VOLUME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION;

CYTOKINES; HEART FAILURE, CONGESTIVE; HEMODIAFILTRATION; HUMANS; INFLAMMATION MEDIATORS; NATRIURETIC PEPTIDE, BRAIN;

EID: 34547843561     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm234     Document Type: Letter

References (4)

1. Libetta C, Sepe V, Zucchi M et al. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant 2007. [Epub ahead of print]
2. Mark PB, Petrie CJ, Jardine AG. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Semin Dial 2007; 20: 40-49
3. Fagugli RM, Palumbo B, Ricciardi D et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003; 95: C60-c66
4. Lee SW, Song JH, Kim GA et al. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 2003; 41: 1257-1266